Use of colchinol derivatives as vascular damaging agents
AssigneeAngiogene Pharmaceuticals Ltd.
InventorGraeme Dougherty
Life of this patent
Estimating the term…
Loading patent…
AssigneeAngiogene Pharmaceuticals Ltd.
InventorGraeme Dougherty
Estimating the term…
Colchinol derivatives of formula wherein R1, R2, R3 and R6 are each independently H, optionally substituted alkyl, cycloalkyl, alkenyl, alkynyl, aralkyl, alkanoyl, PO3H2; X is carbonyl (CO), thiocarbonyl (CS), methylene (CH2) or a group CHR4; R4 is OH, O-alkyl or NR8R9; R5 and R7 are each independently H, alkyl, halogen, hydroxy, alkoxy, nitro or amino; R8 is H, optionally substituted alkyl, cycloalkyl, alkanoyl, thioalkanoyl, aryl, heteroaryl, arylcarbonyl, heteroarylcarbonyl, alkoxycarbonyl, aryloxycarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, arylaminocarbonyl, alkylsulphonyl, arylsulphonyl, aminosulphonyl, alkylaminosulphonyl, dialkylaminosulphonyl or arylaminosulphonyl; and R9 is H, alkyl or cycloalkyl; and the pharmaceutically acceptable salts, solvates, and hydrates thereof have been found to be useful for treatment of diseases involving angiogenesis. Some of these compounds are novel. Particularly preferred are those compounds in which R6 is PO3H2.
A method for the treatment of a disease where inappropriate angiogenesis occurs in a warm-blooded animal comprising administering to said animal a compound of the formula
A compound of the formula
A compound of the formula
A compound of the formula
The compound N-acetylcolchinol-O-phosphate, or a salt, solvate or hydrate thereof.
Dependencies are inferred from the claim text.